Spine News and Research

RSS

Sports-specialization can increase risk of injuries in young athletes

Competitive young athletes are under increasing pressure to play only one sport year round, but such specialization could increase the risk of injuries, a Loyola University Health System study has found.

3 May 2011

AstraZeneca receives FDA approval for NEXIUM I.V. to treat GERD with erosive esophagitis

AstraZeneca announced today that the U.S. Food and Drug Administration has approved the use of NEXIUM I.V. for Injection for children ages greater than 1 month old for the short-term treatment of gastroesophageal reflux disease with erosive esophagitis when oral therapy is not possible or appropriate.

3 May 2011

LSI announces publication of Emerging Medtech Companies report

Life Science Intelligence, a leading medical technology market intelligence firm, has announced the publication of its Report on Emerging Medtech Companies in Q1 2011.

30 Apr 2011

Health Canada approves Eli Lilly's Cymbalta for chronic low back pain treatment

Eli Lilly Canada announced today that Health Canada has approved Cymbalta for the management of chronic low back pain.

30 Apr 2011

Zimmer launches UniWallis Posterior Dynamic Stabilization System in Europe and Asia Pacific

Zimmer Holdings, Inc., a global leader in musculoskeletal care, today announced the launch of the next generation of its Wallis® Posterior Dynamic Stabilization System, the UniWallis™ System, in Europe and Asia Pacific. Since the debut of the Wallis System in 2000, feedback collected from surgeons revealed the need for a device that maintains all of the clinical advantages of the Wallis System, provides improved ease of use and offers a more anatomy-sparing procedure.

29 Apr 2011

Experts to present stem cell therapies for neurological disorders at Cedars-Sinai conference

Experts from stem cell programs at respected research centers around the country will present information at an April 30 conference on stem cell therapy for neurological disorders, hosted by the Department of Neurosurgery at Cedars-Sinai Medical Center in collaboration with the Genetics Policy Institute of Wellington, Fla.

29 Apr 2011

Global Health Partner revenues increase 27% to SEK 178.9 million

Global Health Partner: FIRST QUARTER 2011. Revenues increased by 27 percent to SEK 178.9 million.

28 Apr 2011

Enrollment complete in Unigene's oral PTH Phase 2 osteoporosis study in postmenopausal women

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the Company has completed patient enrollment of its Phase 2 study with an experimental oral parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women.

28 Apr 2011

K2M receives FDA 510(k) clearance for EVEREST Degenerative Spinal System

K2M, Inc., today announced at the International Society for the Advancement of Spine Surgery (SAS) Conference that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the EVEREST™ Degenerative Spinal System, a versatile top-loading polyaxial pedicle screw system featuring the ability to accommodate multiple levels of fixation rigidity to help surgeons individualize patient care.

27 Apr 2011

Advanced Orthopaedics & Spine Medicine to participate in iUni G2 knee implant trial

Dr. David Mack of Advanced Orthopaedics & Spine Medicine and North Cypress Medical Center are participating in a ten year follow-up trial of the ConforMIS iUni® G2 knee resurfacing device, an FDA cleared implant for patients with osteoarthritic damage in a single compartment of the knee.

27 Apr 2011

Synthes, JNJ sign merger agreement for orthopaedics business

Johnson & Johnson, the world's most comprehensive and broadly-based manufacturer of health care products, and Synthes, Inc., a premier global manufacturer of orthopaedic devices, today announced that they have entered into a definitive agreement whereby Johnson & Johnson will acquire Synthes for CHF159 per share, or $21.3 billion.

27 Apr 2011

Accuray announces expiration of HSR waiting period for TomoTherapy acquisition

Accuray Incorporated, a global leader in the field of radiosurgery, today announced the expiration of the mandatory, pre-merger waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, in connection with the previously announced acquisition of TomoTherapy Incorporated.

26 Apr 2011

SI-BONE receives FDA approval for updated iFuse Implant System

SI-BONE, Inc., a medical device company that is pioneering the use of a minimally invasive surgical device to treat the sacroiliac joint announced the U.S. Food and Drug Administration approved a major modification to the existing product label.

26 Apr 2011

Texas Institute for Surgery, StreamVenue partner for innovative endoscopy technology

StreamVenue Healthcare has partnered its "plug and play" products and services with Texas Institute for Surgery At Presbyterian Hospital Dallas to foster innovation in endoscopy technology.

25 Apr 2011

Medtronic's English Channel swimming competition to raise awareness on ALS

In August 2011, Doug McConnell of Barrington, Illinois, expects to be the 48th person over age 50 to successfully swim across the English Channel. He will be swimming more than 21 grueling miles in memory of his father, David, who passed away from ALS.

From Medtronic 25 Apr 2011

Roswell Park Cancer Institute named Blue Distinction Center for Transplants

Roswell Park Cancer Institute (RPCI) has been named a Blue Distinction Center for Transplants® by BlueCross BlueShield of Western New York for demonstrating better overall quality of care and patient results in bone marrow/stem cell (autologous and allogeneic) procedures.

22 Apr 2011

Physiotherapy Associates inaugurates new clinic in Grand Haven, MI

Physiotherapy Associates, the nation's foremost provider of outpatient rehabilitation services, recently opened a new physical therapy clinic in Grand Haven, MI.

22 Apr 2011

DEKRA, Health Canada clear ORTHOCON's new Absorbable Bone Hemostat Matrix

ORTHOCON, Inc., a privately-held therapeutic device company, today announced that DEKRA and Health Canada have cleared its HEMASORB Absorbable Bone Hemostat Matrix for clinical use and sale in Europe and Canada.

22 Apr 2011

Misonix enters new three year distribution agreement with Instrumentacion

Misonix, Inc., a medical device company that designs, manufactures, and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, has entered into a new, three year, exclusive distribution agreement with Instrumentacion, S.A. based in Bogota, Colombia.

22 Apr 2011

Lovelace Medical Center upgrades to Gamma Knife Perfexion system

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today that it has entered into a contract to supply a Gamma Knife® Perfexion™ system to Lovelace Medical Center in Albuquerque, New Mexico.

21 Apr 2011